Abstract
| Original language | English |
|---|---|
| Pages (from-to) | 356 - 362 |
| Number of pages | 7 |
| Journal | Journal of Clinical Psychopharmacology |
| Volume | 33 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2013 |
Cite this
}
Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder. / Kim, Bung-Nyun; Kim, Jae-Won; Cummins, Tarrant Dumas; Bellgrove, Mark Andrew; Hawi, Ziarih; Hong, Soon Beom; Yang, Young Hui; Kim, Hyo Jin; Shin, Min Sup; Cho, Soo-Churl; Kim, Ji Hoon; Son, Jung Woo; Shin, Yun Mi; Chung, Un Sun; Han, Doug Hyun.
In: Journal of Clinical Psychopharmacology, Vol. 33, No. 3, 2013, p. 356 - 362.Research output: Contribution to journal › Article › Research › peer-review
TY - JOUR
T1 - Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder
AU - Kim, Bung-Nyun
AU - Kim, Jae-Won
AU - Cummins, Tarrant Dumas
AU - Bellgrove, Mark Andrew
AU - Hawi, Ziarih
AU - Hong, Soon Beom
AU - Yang, Young Hui
AU - Kim, Hyo Jin
AU - Shin, Min Sup
AU - Cho, Soo-Churl
AU - Kim, Ji Hoon
AU - Son, Jung Woo
AU - Shin, Yun Mi
AU - Chung, Un Sun
AU - Han, Doug Hyun
PY - 2013
Y1 - 2013
N2 - Noradrenergic dysfunction may be associated with cognitive impairments in attention-deficit/hyperactivity disorder (ADHD), including increased response time variability, which has been proposed as a leading endophenotype for ADHD. The aim of this study was to examine the relationship between polymorphisms in the a-2A-adrenergic receptor (ADRA2A) and norepinephrine transporter (SLC6A2) genes and attentional performance in ADHD children before and after pharmacological treatment.
AB - Noradrenergic dysfunction may be associated with cognitive impairments in attention-deficit/hyperactivity disorder (ADHD), including increased response time variability, which has been proposed as a leading endophenotype for ADHD. The aim of this study was to examine the relationship between polymorphisms in the a-2A-adrenergic receptor (ADRA2A) and norepinephrine transporter (SLC6A2) genes and attentional performance in ADHD children before and after pharmacological treatment.
UR - http://www.ncbi.nlm.nih.gov/pubmed/23609393
U2 - 10.1097/JCP.0b013e31828f9fc3
DO - 10.1097/JCP.0b013e31828f9fc3
M3 - Article
VL - 33
SP - 356
EP - 362
JO - Journal of Clinical Psychopharmacology
JF - Journal of Clinical Psychopharmacology
SN - 0271-0749
IS - 3
ER -